Apps

openserveblockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

News

Home
Politics
World
Sports
Markets
Business
Entertainment
Music
Health
Tech
Science
Good News

Want your own hosted, self-optimizing clone of this — or any OpenServe site? Open Development for enterprise →

© OpenServe Holdings LLC

Privacy Notice Data rights Terms of Service Feedback Cookie NoticeHelp Acceptable Use Copyright AI Notice Your Privacy Choices Subprocessors Data Processing Addendum Installed App Terms Company Solutions Free assessment Investors Get the app Contact

IJR News — today's news from every side

Mimrylo earns FDA approval for Polycythemia VeraHealth — 4dFDA approved Takeda’s Mimrylo (rusfertide), a first-in-class hepcidin mimetic for erythrocytosis in adults with polycythemia vera, to keep hematocrit below 45% and reduce phlebotomy burden. In the phase 3 VERIFY trial, 76.9% of patients achieved a clinical response, signaling a potential shift in PV treatment and paving the way for broader access worldwide.

Telix Q2 Revenue Up 21% to $247MBusiness — Jul 20, 2026Telix Pharmaceuticals reported US$247 million in Q2 2026 group revenue, up 21% year over year and 7% quarter over quarter, with the Precision Medicine unit delivering US$202 million and leading growth. The company reaffirmed FY2026 guidance to exceed US$1 billion, supported by a US$40 million Regeneron inflow, FDA alignment for TLX591-Tx Phase 3, progress in the BiPASS pre-biopsy program, and ongoing manufacturing expansions and strategic initiatives with Regeneron.